Parenteral Drugs (India)

quarterly
yearly
ParticularsMar '21Jun '21Sep '21Dec '21Mar '22
Revenue2.602.942.361.451.81
Expenses35.9644.0045.4245.6834.81
EBITDA3.42-2.63-3.26-3.22-5.85
EBIT-0.90-6.95-7.58-7.5519.21
Profit Before Tax-33.35-41.06-43.05-44.2219.21
Net Profit-24.84-32.04-33.61-34.5223.81
Financial Ratios
Operating Profit Margin133.07%-89.42%-138.72%-222.92%2,620%
Net Profit Margin-966.54%-1,094%-1,430%-2,397%-1,605%
Earning Per Share (Diluted)-8.33-10.74-11.28-11.587.99
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ